Home › Macrophage Therapeutics Produces First Two Immunoconstructs
 

Keywords :   


Macrophage Therapeutics Produces First Two Immunoconstructs

2015-09-28 06:00:20| chemicalonline Home Page

Macrophage Therapeutics, Inc., a subsidiary of Navidea Biopharmaceuticals, Inc., recently announces that it has developed a process for producing the first two therapeutic Manocept immunoconstructs, MT-1001

Tags: produces therapeutics

Category:Chemicals

Latest from this category

All news
12.11Benjamin Moore Expands Partnership with Roadie to Accelerate Paint Delivery for DIYers and Pros
11.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
11.11Protech Group Acquires Caldwell Chemical Coatings
11.11Asian Paints Reports 2Q 2024-25 Fiscal Results
10.11Clariant Launches Melamine-free Flame Retardant for Intumescent Coatings
Chemicals »
24.11Costume
24.11BB S604ULS
24.1133
24.11 ElectronicAudioExperimentsDude Incedible
24.11 TC101 5IP 6 NS.NEO 950GH S
24.11
24.11
24.11
More »